Hypertension  >>  Tracleer (bosentan)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
NCT00432978: Effect of Bosentan on Exercise Capacity at High Altitude

Completed
1
20
US
Bosentan administration
VA Loma Linda Health Care System, Actelion
Altitude, Pulmonary Hypertension
 
02/07
NCT00260819: Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia

Completed
1
20
Europe
Bosentan, TRACLEER, Bosentam TRACLEER
Assistance Publique - Hôpitaux de Paris
Hypoxia-Induced Pulmonary Artery Hypertension
04/08
04/08
NCT01100736: Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)

Completed
1
10
Europe
Bosentan, Tracleer, Sitaxsentan, Thelin, Placebo, Endothelin-3
University of Edinburgh, Encysive Pharmaceuticals
Pulmonary Arterial Hypertension, Vasodilation, Vasoconstriction
09/09
01/10
NCT01864863: To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers

Completed
1
28
RoW
HGP1206, Bosentan 125 mg, Traclear, Traclear 62.5 mg
Hanmi Pharmaceutical Company Limited
Pulmonary Arterial Hypertension
05/13
05/13
ACTRN12615000281594: Comparative assessment of the absorption of a generic formulation of bosentan film-coated tablet against the innovator bosentan film-coated tablet conducted under fasting conditions in healthy male volunteers

Completed
1
56
 
Zenith Technology Corp Ltd, Novotech (Australia) Pty Ltd
Bioequivalence study conducted in healthy volunteers comparing two formulations of bosentan with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for the condition to which the medicine is used, bosentan is an endothelin receptor antagonist that belongs to a class of highly substituted pyrimidine derivatives and is indicated for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with schleroderma or pulmonary arterial hypertension assocated with congenital or systemic to pulmonary shunts including Eisenmenger's physiology.
 
 
NCT00223717: Treatment of Supine Hypertension in Autonomic Failure

Completed
1
152
US
Clonidine, Catapres, Nitroglycerin transdermal, Nitro-Dur, Dipyridamole/ Aspirin (Aggrenox), Aggrenox, Desmopressin (DDAVP), DDAVP, Sildenafil, Viagra, Nifedipine, Adalat, Hydralazine, Hydrochlorothiazide, Microzide, Placebo, Bosentan, Tracleer, Diltiazem, Cardizem, Eplerenone, Inspra, guanfacine, Tenex, L-arginine, captopril, capoten, carbidopa, Lodosyn, losartan, cozaar, metoprolol tartrate, lopressor, nebivolol hydrochloride, Bystolic, prazosin hydrochloride, Minipress, tamsulosin hydrochloride, Flomax, Head-up tilt., HUT, aliskiren, Tekturna, Local heat stress, heating pad
Vanderbilt University
Hypertension
01/17
01/17
BIA-51058-107, NCT04991207: Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Completed
1
44
Europe
BIA 5-1058, Zamicastat, bosentan, Tracleer
Bial - Portela C S.A.
Pulmonary Arterial Hypertension
05/18
05/18

Download Options